Gufic Biosciences has received approval from the National Medical Products Administration (NMPA) in China for its product, Prilocaine (API), an amide-type local anesthetic. The approval will aid in the commercialization of Prilocaine in China, opening up new opportunities in the Chinese market for Gufic. Prilocaine, which shares a similar clinical profile to lidocaine, is used […]
Zydus Lifesciences has secured final approval for Isoproterenol Hydrochloride (HCL) Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials from the US Food and Drug Administration (FDA). The approved product is a generic version of Isuprel Injection. Isoproterenol hydrochloride injection has been approved for improving hemodynamic status in patients in distributive shock […]
Caplin Point Laboratories said that Caplin Steriles has been given final approval for Rocuronium Bromide Injection, 10 mg/mL in 5 mL and 10 mL Multi-dose Vials from the US Food and Drug Administration (FDA). Caplin Steriles is a sterile product manufacturing company owned by Caplin Point Laboratories. Rocuronium Bromide Injection is a generic therapeutic equivalent […]
Fresenius Kabi, the global German healthcare company, has unveiled Methocarbamol Injection, USP in the United States, marking a significant expansion of its anesthesia and analgesia portfolio. The 100 mg per mL, 10 mL vial presentation is designed to assist in relieving the discomfort associated with acute, painful musculoskeletal conditions. This new injectable treatment, which can […]